Scrapie is a naturally occurring fatal neurodegenerative disease of sheep and goats. Susceptibility to the disease is partly dependent on the genetic makeup of the host. This study documents clinicopathological findings and the distribution of abnormal prion proteins (PrP res ) by immunohistochemical and Western blot techniques, in tissues of genetically susceptible sheep inoculated with US sheep scrapie agents. Four-monthold Suffolk lambs (QQ or HQ at codon 171) were inoculated (5 intracerebrally and 19 orally) with an inoculum (#13-7) consisting of a pool of scrapie-affected sheep brains. Intracerebrally inoculated animals were euthanized when advanced clinical signs of scrapie were observed. Orally inoculated animals were euthanized at predetermined time points (4, 9, 12, 15, and 21 months postinoculation [PI]) and thereafter when the animals had terminal signs of disease. All intracerebrally inoculated animals exhibited clinical signs of scrapie and were euthanized between 13 and 24 months PI. Spongiform lesions in the brains and PrP res deposits in central nervous system and lymphoid tissues were present in these sheep. In orally inoculated sheep, clinical signs of scrapie were seen between 27 and 43 months PI in 5/9 animals. The earliest detectable PrP res was observed in brainstem and lymphoid tissues of a clinically normal, orally inoculated sheep at 15 months PI. Three of the 4 clinically normal sheep were positive at 15, 20, and 49 months PI by PrP res immunohistochemistry.
Introduction
Scrapie is a naturally occurring disease of sheep and goats. Infection by the causative agent, considered to be the posttranslationally modified form of a host-encoded membrane glycoprotein (PrP c ), leads to spongiform encephalopathy and accumulation of an abnormal form of prion protein (PrP res ) in tissues of the nervous and lymphoid systems. Susceptibility to scrapie is partially dependent on genetic variation of the host, 1, 10 and in sheep, polymorphisms of the PrP gene at codons 136 (valine or alanine), 154 (histidine or arginine), and 171 (glutamine, arginine, or histidine) are the dominant factors. 1, 10 In an experimental study in the United States of orally inoculated Suffolks, 61% developed scrapie. All were homozygous for glutamine (QQ) at the 171 allele. 13 This study documents histopathological, immunohistochemical (IHC), and Western blot (WB) findings in genetically susceptible sheep inoculated orally and intracerebrally with sheep scrapie. Because there is a paucity of information on experimental studies of US From the National Animal Disease Center, ARS, USDA, 2300 Dayton Avenue, PO Box 70, Ames, IA 50010 (Hamir, Kunkle, Richt, Miller, Cutlip) , and Pathobiology Laboratory, National Veterinary Services Laboratories, 1800 Dayton Road, Ames, IA 50010 (Jenny). 1 Corresponding Author: Amir N. Hamir, National Animal Disease Center, ARS, United States Department of Agriculture, 2300 Dayton Avenue, PO Box 70, Ames, IA 50010. scrapie transmission in genetically susceptible sheep, this investigation attempts to fill this void.
Material and methods
Twenty-four 4-mo-old Suffolk lambs (17 intact males and 7 females; all QQ or HQ at 171) from 2 scrapie-free flocks were obtained for this study. The animals were inoculated either intracerebrally (n ϭ 5) with 1 ml of inoculum or orally (n ϭ 19) with 2 doses of 15 ml of inoculum, which were administered 1 wk apart (Table 3 ). For the purpose of negative control tissues, 2 scrapie-free non-inoculated sheep were selected.
The inoculum (#13-7) was prepared from a pool of 13 scrapie-affected sheep brains (all were positive by immunohistochemistry) from 7 source flocks. The inoculum was ground in a mechanical grinder, gentamicin was added at 100 g/ml, and the final concentration of 10% (w/v) was made with phosphate-buffered saline.
The procedure for intracerebral inoculation of lambs has been described previously. 2 Briefly, the animals were sedated with xylazine, a midline incision was made in the skin at the junction of the parietal and frontal bones, and a 1-mm hole was drilled through the calvarium. The inoculum (1 ml of 10% w/v brain suspension) was injected into the midbrain through a 22-gauge, 9-cm-long needle while withdrawing the needle from the brain. The skin incision was closed with a single suture. Oral inoculations were done with a syringe fitted with a short (6 inches) clear plastic tube, and the inoculum (2 doses of 15 ml of 10% w/v brain suspension administered 7 days apart) was slowly injected in the mouth so that the lambs were able to swallow the inoculum. The 2 control lambs were not inoculated.
Inoculated animals were initially housed in a biosafety level-2 containment facility (2 per pen) and later were moved to outside pens at the National Animal Disease Center (NADC), Ames, Iowa. The sheep were fed pelleted growth and maintenance rations that contained no ruminant protein, and clean water was available ad libitum. Control sheep were kept with the scrapie-free sheep flock at NADC. Both groups were fed pelleted growth ration and alfalfa hay.
At predetermined time points (4, 9, 12, 15 , and 21 mo postinoculation [PI]), 1 or 2 lambs from the orally infected group were euthanized (Table 1) . One uninoculated control sheep was euthanized with the first group of inoculates at 4 mo and the other was euthanized at termination of the study. These and other sheep that died or were euthanized during the experimental period were examined at necropsy, and 2 sets of tissue samples were collected. One set of tissues included representative sections of liver, kidney, spleen, skin, striated muscles (heart, tongue, diaphragm, masseter), thoracic aorta, thyroid gland, turbinates, trachea, lung, tonsils, esophagus, rumen, reticulum, omasum, abomasum, intestines (ileum), adrenal gland, urinary bladder, lymph nodes (retropharyngeal, prescapular, mesenteric, popliteal), nerves (sciatic, optic, trigeminal), pituitary gland, Gasserian ganglion, brain (cerebral cortex, cerebellum, midbrain including superior colliculi, brainstem including obex), spinal cord (cervical, thoracic, lumbar), and eye (retina). These tissues were fixed in 10% buffered formalin, embedded in paraffin wax, sectioned at 5 m, and stained with hematoxylin and eosin (HE) for light microscopy. The second set of tissues was frozen.
All paraffin-embedded tissues were also stained by an automated immunohistological method for detection of PrP res as described previously. 11 Briefly, after deparaffinization and rehydration, tissue sections were autoclaved for 30 min in an antigen retrieval solution a and stained with an indirect avidin-biotin system b designed for an automated immunostainer. c The primary antibody was a cocktail of 2 monoclonal antibodies, F89/160.1.5 12 and F99/97.6.1, 14 each used at a concentration of 5 g/ml, and incubation was carried out at 37 C for 32 min. The secondary antibody was biotinylated anti-mouse, d diluted 1:200 and incubated for 8 min at 37 C. The second set of tissues was frozen.
The brain was cut longitudinally and 1 half of the brainstem and medulla were fixed in formalin for histopathology and immunohistochemistry. The remaining 1 half of the brain was frozen for immunodetection of PrP res by a commercial WB e described previously 6 and by a modified WB technique. Briefly, the modification consisted of the use of a secondary biotinylated anti-mouse antibody (dilution 1: 10,000), f followed by a streptavidin-horseradish peroxidase conjugate (dilution 1:10,000). g The blot was developed with an ECL Plus chemiluminescence solution h before being exposed to film.
Results
All 5 intracerebrally inoculated sheep developed clinical scrapie and were euthanized between 13 and 24 months (mean, 570 days) PI (Tables 2, 3 ). Initial clinical signs consisted of a progressive decrease in appetite and associated weight loss. Later, the affected sheep developed fine head tremors, listlessness, progressive problems with locomotion, and terminal sternal recumbency. None of the affected sheep exhibited obvious pruritus or loss of wool from their fleece.
In the orally inoculated group, although the earliest detectable PrP res by IHC was observed at 15 months PI in the brain and lymphoid tissues, none of the sheep had either spongiform lesions or showed clinical signs of scrapie before 24 months PI ( Table 1) . Clinical scrapie was observed in 5/9 sheep that survived over the age of 24 months PI ( Table 2 ). In these animals the survival period was longer than in the intracerebrally inoculated sheep (between 27 and 43 months, mean 956 days PI, Tables 2, 3 ), but clinical signs were identical to the sheep inoculated intracerebrally.
During the incubation period, 3 orally inoculated sheep (Nos. 10, 12, and 17; Table 1 ) were euthanized between 17 and 25 months PI because of gastrointestinal disease. All 3 had extensive multifocal erosions and ulcers on mucosal surfaces of the esophagus and or abomasum. However, microscopic examinations of the affected areas failed to show any pathogens, and the IHC tests were negative for bovine viral diarrhea virus antigen and PrP res .
Orally inoculated sheep that did not succumb to scrapie (n ϭ 2; Table 1 ) and the remaining control animal were euthanized between 49 and 50 months PI (Table 1 ). In addition to the 5 clinical scrapie cases, there were 3 other nonclinical animals (orally inoculated) that were considered positive for the disease. One of these was positive by histopathology, IHC, and WB (subclinical case), and the other 2 were considered preclinical cases with positive PrP res in only the brainstem by the IHC method ( Table 1) .
The distribution of histologic lesions (Figs. 1, 3, 5) and the results of PrP res IHC (Figs. 2, 4, 6, 7) and WB assays ( Fig. 8 ) in intracerebrally and orally inoculated sheep are given in Table 1 . In clinical animals, microscopic spongiform lesions characteristic of prion disease were present in both intracerebrally and orally inoculated sheep ( Figs. 1, 3, 5 ). Subjectively, the lesions appeared to be more severe in the sheep brains that had received the inoculum via the intracerebral route. Such lesions were found in the cerebrum and brainstem regions of 10 of 10 sheep (Figs. 1, 5), cerebellum (8/10 sheep; Fig. 3 ), and spinal cord (9/10 sheep).
In general, for examination of brain tissue for diagnosis of scrapie, there was agreement between the 3 tests (histopathology, IHC, and WB) in clinical cases. In addition, a positive (subclinical) case (No. 9096; Table 1 ) was detected by histopathology and IHC tests. However, the IHC was able to identify 2 additional cases (Nos. 9086 and 2142; Table 1 ). As for the examination of lymph nodes for PrP res , the WB did not reveal any positive cases (Table 1) .
At the time of necropsy, 1 of the intracerebrally inoculated ewes (No. 15; Table 1 ), which had developed clinical signs of scrapie at 22 months PI, was found to be pregnant with twins of approximately 4 weeks gestation. Brain and spinal cord of this ewe showed spongiform lesions and were positive for PrP res by both IHC and WB (Table 1 ). Immunohistochemical staining of the uterine section did not reveal a positive reaction, and 1 of the examined fetus (the other fetus was frozen) was also negative for PrP res by IHC.
In addition to the IHC data presented in Table 1 , third eyelid samples with detectable submucosal lymphoid aggregates were seen in 10 of the 13 sheep with IHC positive brains; however, none were positive. Spinal cord-associated dorsal root ganglia were seen in 9 of the 13 IHC-positive sheep; 3 of the 9 had abnormal PrP res in dorsal root ganglia. In 5 orally inoculated sheep that were sacrificed at 30 or more months PI, PrP res was detected in spleen (n ϭ 3), in adrenal medulla (n ϭ 2), and pituitary gland (n ϭ 3).
Immunohistochemically stained tissue sections of non-central nervous system (CNS) and nonlymphoid tissues, including striated muscles (heart, tongue, diaphragm, and masseter muscle), did not reveal PrP res staining.
Discussion
Scrapie is a genetically influenced fatal neurodegenerative disease of sheep. The PRNP gene determines relative resistance or susceptibility to scrapie. Suffolks with QQ or HQ at codon 171 are considered highly susceptible to scrapie. 13, 17 Before 1995, several experimental studies using scrapie agents in Suffolks were reported; 4,5 however, at that time the genetic impact on development of clinical disease was not recognized.
There is a paucity of information on experimental studies in Suffolks in the United States, and studies of intracerebral and oral inoculations of US scrapie agent have not been documented previously.
Results of this investigation showed that when scrapie inoculum was injected directly into the brain, a long incubation time was required (mean 570 Ϯ 133 days PI) before the disease manifested clinically. In orally inoculated animals given a large dose (30 ml of 10% brain suspension), an even longer time (mean 956 Ϯ 196 days PI) was required for development of clinical disease. Furthermore, clinical disease was ob- * 10% brain suspension (w/v). † Sheep that lived over 24 mo (3 additional subclinical or preclinical cases were detected in this group).
Figure 8.
Western blot analysis of brain and lymphoid tissues from scrapie-infected sheep. A distinct profile of the 3 polypetide forms of PrP res is shown for brain (obex) tissues of 2 scrapie-positive animals (Nos. 6 and 21; Table 1 ), whereas retropharyngeal lymph nodes from these sheep are negative for PrP res . Scrapie-positive brain and scrapie-negative brain controls are in lanes 2, 3, and 4. Molecular weight markers are shown on both sites of the immunoblot. served in only 5/8 sheep that were allowed to live for over 4 years PI. In a previous study, 12 genetically susceptible (QQ at 171) Suffolks administered a similar oral dose (30 ml of 10% brain suspension) of inoculum survived for a considerably shorter time (mean 622 days PI). Because the inoculum used in the previously published study (third-and fourth-passaged scrapie) was different from this study (pool from 13 scrapie positives from 7 source flocks), the difference in survival time of orally inoculated sheep in the 2 studies may be attributed to the inoculum that was used. It could also be argued that the experimental sheep used in the previous study may have been genetically different at other loci (at codons 136 and 154), making them more susceptible to scrapie. Genetic analysis of the experimental sheep in this study revealed only 1 animal with VA at codon 136, and the remainder of the animals were all AA at codon 136 and RR at codon 154 ( Table 1) .
The clinical signs of scrapie vary widely in individual sheep. In general, the early signs are subtle changes in behavior or temperament followed by obvious progressive neurologic signs. 3 The latter include incoordination, trembling, rapid movements of the tongue and lips, grinding of teeth, and pruritis. In terminal cases, there is often weight loss and debilitation. 16 In the clinical cases of this study, reduced dietary intake with subsequent weight loss and terminal debilitation and recumbancy were the predominant signs.
Currently, the available methods for routine diagnosis of scrapie are demonstration of characteristic histological changes and detection of PrP res by IHC and WB in the brains of affected animals. 8 Previously it was found that the IHC test has equal, if not slightly superior, sensitivity for detection of PrP res in brain tissues, 8 and in this investigation this observation also appears to be true. Although in this study only 10 sheep showed clinical signs of scrapie and all 10 brains were positive by histopathology, IHC, and WB (Table  1) , 3 additional orally inoculated animals (Nos. 8, 12, and 23; Table 1 ) were found positive. Based on the presence of histologic lesions, animal No. 23 was considered subclinical for the disease; whereas Nos. 8 and 12 were preclinical (only positive on IHC). Because similar cases have been seen previously in naturally infected scrapie flocks, this was not a surprising finding. 8 In this study, 4/5 intracerebrally inoculated sheep were positive for PrP res in both CNS and in at least 1 lymphoid tissue by IHC ( Table 1 ). The presence of PrP res in lymphoid tissues can be attributed to the fact that the affected animals were euthanized when they had generalized and advanced clinical disease and, therefore, at that time PrP res might be expected to be present in those tissues. However, it must also be realized that during the intracerebral inoculation of scrapie, there is probably sufficient damage to the bloodbrain barrier to allow access of PrP res into the vascular system. 9 PrP res was not detected by the WB technique in homogenates of IHC-positive lymph nodes. Most likely, either the method used for tissue preparation was suboptimal or the WB technique for detection of PrP res in lymph nodes was not sensitive enough. Extraction of lymph node homogenates to enrich PrP res as well as the use of PrP-specific antibodies with a higher sensitivity than monoclonal antibody 6H4 for the detection of the sheep scrapie agent need to be considered for future WB analyses of lymphoid tissues. The antibodies used in this study for the detection of PrP res by IHC or WB were of different origin and most likely recognized different epitopes within the prion protein polypeptide.
It has been documented in pregnant Suffolks (that are QQ at codon 171 and over 40-days gestation) with clinical scrapie that PrP res is present in placentomes and placental tissues of most ewes. 15 Therefore, negative findings of PrP res in the uterus of the pregnant ewe (No. 15; Table 1 ) and in its fetus is interesting and can probably be attributed to the less than 40-day gestation period of the fetus. 15 Immunohistochemistry did not reveal positive PrP res antigen in striated muscles of either clinical or nonclinical animals. This observation is in agreement with our previous findings in which striated muscle tissues (tongue, heart, diaphragm, and masseter muscle) from 20 animals (cattle, sheep, elk, and raccoons) were examined for PrP res by IHC. 7 In these animals, all of which had developed transmissible spongiform encephalopathy after experimental inoculation, PrP res was found by IHC in the brains but not in muscle tissues. 7 There is a lack of information on experimental transmission of US scrapie agents in genetically diverse flocks of sheep. This study attempts to partially fill this void by documenting the pathogenesis of this disease after oral and intracerebral inoculation in Suffolks. Similar investigations are also needed for other breeds of sheep in this country.
